Coreg CR Once-Daily Sustains Blood Pressure Reduction Over 24 Hours, Study Finds
This article was originally published in The Pink Sheet Daily
Executive Summary
The controlled-release version of GlaxoSmithKline’s beta blocker carvedilol has an estimated user fee date of late October.